Advertisement
Advertisement
U.S. markets open in 58 minutes
Advertisement
Advertisement
Advertisement
Advertisement

InnoCan Pharma Corporation (INNO.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.8600-0.0200 (-2.27%)
At close: 03:48PM EST
Advertisement
Full screen
Loading interactive chart...
  • Newsfile

    Innocan Pharma Announces the Successful Demonstration of Prolonged Release of CDB in Dogs Using Its LPT Technology

    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 18, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce that in its recent study of its CBD-loaded liposome technology (LPT) on dogs, CBD showed prolonged plasma concentrations for at least six weeks after a single administration. These results are significant advance in the development of the technology demonstrating the advantages of LPT in dogs, ...

  • Newsfile

    Innocan Pharma to Participate in the Lift & Co. Expo's Business Growth Panel on November 19th, 2021

    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 15, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce that CEO Iris Bincovich will be participating in the Industry Day Main Panel at the Lift & Co. Expo, on November 19, 2021, in Toronto. The panel, titled "Business Growth Update: Canadian Business for today's International Cannabis Marketplace", will include some of the world's leading companies ...

  • Newsfile

    Innocan Pharma Reports Further Success in Profile Characterization Progress In Its micro-RNA Cannabinoids Loaded Exosome Delivery Platform (CLX) Project

    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 10, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to report further progress in the Cannabinoids loaded Exosome Delivery Platform (CLX) research. The researchers at Prof. Offen's laboratory at the Tel Aviv University, have succeeded to characterize the profile of the micro-RNA content in exosomes. The new analysis will allow more accurate characterization of the e

Advertisement
Advertisement